USPTO serial 79292951
NANOBIOTIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 15, 2021
- Examiner
- ADEYIGA, ADETAYO JANET
- Law office
- TMEG LAW OFFICE 109
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with NANOBIOTIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James R Menker
James R Menker Holley & Menker, PAPO Box 331937Atlantic Beach, FL 32233UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, preparations for medical use particularly for tumor diagnosis and treatment; pharmaceutical products, namely, preparations for medical use, especially for the diagnosis and treatment of tumors using radiotherapy; radioactive products, namely, substances for medical use, especially for the diagnosis and treatment of tumors using radiotherapy; health products, namely, pharmaceutical products, for the treatment of tumors; radiological contrast substances for medical use; chemical reagents for medical use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of tumors; diagnostic products for medical use, namely, medicines for the treatment of tumors; drugs for medical use, namely, pharmaceutical products for use in the treatment of cancer; medicines for human medicine, namely, pharmaceutical products for the treatment of tumors; chemico-pharmaceutical products for use in treating oncological diseases and disorders; pharmaceutical products for use in treating oncological diseases and disorders | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments, namely radiotherapy apparatus especially for the diagnosis and treatment of tumors using radiotherapy; radiotherapy apparatus; testing apparatus for medical use, namely, for testing tumor characteristics; diagnostic apparatus for medical use, namely, for testing tumor characteristics; radiological apparatus for medical use; apparatus and installations for the production of X-Rays for medical use | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design services particularly in the field of nanomedicine which is nanotechnology applied to medicine; biological research; research in bacteriology; scientific research, namely, evaluations, estimates and research in scientific and technological fields provided by engineers, researchers; design and development of new products for third parties; technical project studies, namely, technical research in the field of nanomedicine; industrial analysis of manufacturing of nanomedicines and research services in the field of nanomedicine; chemical analysis; chemical research; chemistry services, namely, chemistry consultation; surveying | ACTIVE | — |
| 044 | Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nanobiotix
- Other trademarks owned by Nanobiotix
- Other trademarks owned by Nanobiotix
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NANOBIOTIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 3, 2022 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 23, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 1, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 15, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 15, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 28, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 10, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 10, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 24, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 24, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 24, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 24, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 9, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |